These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 6243720)

  • 21. Use of an electroimmunodiffusion method on cellulose acetate films for the detection of antigenicity in human breast cancers that is related to the major core antigen of mouse mammary tumor virus (MuMTV).
    Kryukova IN; Komarova E; Zotter S; Grossmann H
    Arch Geschwulstforsch; 1981; 51(6):517-21. PubMed ID: 6277267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor immunity in breast cancer patients. Biologic and therapeutic implications.
    Black MM; Zachrau RE
    J Reprod Med; 1979 Jul; 23(1):21-32. PubMed ID: 226697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological studies in breast cancer. Modifying activity of the serum (MSA).
    Cervantes C; Muzio E; Exposito G; Garcia ME
    Neoplasma; 1980; 27(4):379-86. PubMed ID: 7453855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
    Halliday WJ; Koppi TA; Khan JM; Davis NC
    J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay for protein p28 of murine mammary tumor virus in organs and serum of mice and search for related antigens in human sera and breast cancer extracts.
    Hendrick JC; François C; Calberg-Bacq CM; Colin C; Franchimont P; Gosselin L; Kozma S; Osterrieth PM
    Cancer Res; 1978 Jun; 38(6):1826-31. PubMed ID: 206358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumor immunity in breast cancer evaluated by a computerized tube leukocyte adherence inhibition (LAI) assay.
    Fink A; Shani A; Feldman B; Wechsler U; Pfeffermann R; Eliraz A; Offer S; Harpaz N; Bentwich Z
    Eur J Surg Oncol; 1989 Feb; 15(1):17-9. PubMed ID: 2645173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Leukocyte migration inhibition and leukocyte adherence inhibition (LMI- and LAI-assay) in cancer patients by using preparations from human fetuses].
    Albrecht S; Thuy LT; Pasternak G; Schlott B; Reinhöfer J; Lunow E; Loewe G; Gütz HJ
    Acta Biol Med Ger; 1978; 37(11-12):1747-57. PubMed ID: 382722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peripheral leukocyte migration inhibition reactivity to breast cancer antigens in patients with breast cancer and in normal controls.
    Brandes LJ; Goldenberg GJ
    Cancer Res; 1976 Oct; 36(10):3707-10. PubMed ID: 953996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell-mediated antitumor immunity in breast cancer patients evaluated by antigen-induced leukocyte adherence inhibition in test tubes.
    Grosser N; Thomson DM
    Cancer Res; 1975 Sep; 35(9):2571-9. PubMed ID: 1097110
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
    Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
    Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequence homology of nucleic acids from human breast cancer cells and complementary DNA's from murine mammary tumor virus and Mason-Pfizer monkey virus.
    Das MR; Mink MM
    Cancer Res; 1979 Dec; 39(12):5106-13. PubMed ID: 227595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the LAI test in patients with benign and malignant breast diseases.
    Kovarík J; Lauerová L; Ninger E; Munzarová M; Feit J; Zemanová D; Wotke R
    Neoplasma; 1983; 30(2):163-7. PubMed ID: 6843721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies reactive with the mouse mammary tumor virus in sera of breast cancer patients.
    Witkin SS; Sarkar NH; Kinne DW; Good RA; Day NK
    Int J Cancer; 1980 Jun; 25(6):721-5. PubMed ID: 14768700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sensitization of leukocytes of cancer patients against fetal antigens: leukocyte migration studies.
    Zöller M; Matzku S; Schulz U; Price MR
    J Natl Cancer Inst; 1979 Aug; 63(2):285-93. PubMed ID: 88534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostically favorable immunogens of human breast cancer tissue: antigenic similarity to murine mammary tumor virus.
    Black MM; Zachrau RE; Shore B; Moore DH; Leis HP
    Cancer; 1975 Jan; 35(1):121-8. PubMed ID: 162850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leukocyte migration inhibition and lymphocyte blastogenesis responses in breast carcinoma patients to mouse mammary tumor virus and to virion gp52 antigen and Rauscher murine leukemia virus-Kirsten sarcoma virus gp69/71 antigen.
    McCoy JL; Dean JH; Cannon GB; Jerome LJ; Alford TC; Parks WP; Gilden RV; Oroszlan ST; Herberman RB
    J Natl Cancer Inst; 1978 Jun; 60(6):1259-67. PubMed ID: 206704
    [No Abstract]   [Full Text] [Related]  

  • 38. Breast cancer and T-cell-mediated immunity to proteins of the mouse mammary tumour virus (MMTV).
    de Ricqlès D; Olomucki A; Gosselin F; Lidereau R
    Eur Cytokine Netw; 1993; 4(2):153-60. PubMed ID: 8391340
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
    Emmrich F; Ambrosius H
    Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunopathology of breast cancer.
    Black MM
    Pathobiol Annu; 1977; 7():213-30. PubMed ID: 201905
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.